Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ)
CNY 28.56
(-1.52%)
CNY 28.56
(-1.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.04 Billion | 667.93 Million | 907.43 Million | 904.56 Million | 821.46 Million | 687.94 Million |
| Cost of Revenue | 615.25 Million | 427.02 Million | 536.52 Million | 568.21 Million | 506.13 Million | 414.32 Million |
| Gross Profit | 433.24 Million | 240.9 Million | 370.91 Million | 336.34 Million | 315.33 Million | 273.62 Million |
| Operating Expenses | 184.1 Million | 123.73 Million | 133.87 Million | 124.33 Million | 113.32 Million | 88.03 Million |
| Selling, General and Administrative Expenses | 65.56 Million | 45.27 Million | 44.95 Million | 47.68 Million | 48.71 Million | 42.06 Million |
| Research and Development Expenses | 55.76 Million | 35.86 Million | 47.58 Million | 45.09 Million | 40.16 Million | 23.7 Million |
| Other Expenses | 66.13 Million | 42.6 Million | 41.32 Million | 31.54 Million | 24.44 Million | 1.35 Million |
| Cost and Expenses | 801.19 Million | 550.76 Million | 670.39 Million | 692.55 Million | 619.45 Million | 502.36 Million |
| Operating Income | 247.3 Million | 138.16 Million | 241.74 Million | 220.64 Million | 199.14 Million | 182 Million |
| Interest Expense | 14.33 Million | 2.05 Million | 2.77 Million | 1.05 Million | 399.68 Thousand | 3.75 Million |
| Income Tax Expense | 27.9 Million | 16.19 Million | 36.18 Million | 29.45 Million | 27.14 Million | 25.18 Million |
| Earnings before Tax | 245.45 Million | 137.31 Million | 241.17 Million | 219.04 Million | 198.29 Million | 181.82 Million |
| Net Income | 218.65 Million | 117.51 Million | 205.43 Million | 190.39 Million | 171.34 Million | 156.63 Million |
| Earnings Per Share Basic | 0.96 | 0.52 | 0.91 | 0.84 | 0.76 | 0.69 |
| Earnings Per Share Diluted | 0.96 | 0.52 | 0.91 | 0.84 | 0.76 | 0.69 |
| Weighted Average Shares Outstanding | 226.8 Million | 226.8 Million | 226.8 Million | 226.8 Million | 226.79 Million | 226.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 226.8 Million | 226.8 Million | 226.8 Million | 226.8 Million | 226.79 Million | 226.8 Million |
| Gross Margin | 0.41 | 0.36 | 0.41 | 0.37 | 0.38 | 0.40 |
| EBIT Margin | 0.33 | 0.28 | 0.33 | 0.29 | 0.29 | 0.33 |
| Profit Margin | 0.21 | 0.18 | 0.23 | 0.21 | 0.21 | 0.23 |
| EBITDA | 350.21 Million | 207.18 Million | 301.46 Million | 266.69 Million | 238.63 Million | 227.55 Million |
| Earnings Before Tax Margin | 0.24 | 0.21 | 0.27 | 0.24 | 0.24 | 0.26 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 331.19 Million | 294.12 Million | 226.3 Million | 1.04 Billion | 313.07 Million | 278.26 Million |
| Cost of Revenue | 193.21 Million | 180.05 Million | 128.36 Million | 615.25 Million | 195.34 Million | 155.46 Million |
| Gross Profit | 137.98 Million | 114.07 Million | 97.94 Million | 433.24 Million | 117.72 Million | 122.8 Million |
| Operating Expenses | 45.63 Million | 34.39 Million | 37.61 Million | 184.1 Million | 52.56 Million | 58.61 Million |
| Selling, General and Administrative Expenses | 64.02 Million | 27.9 Million | 25.18 Million | - | -16.33 Million | 54.22 Million |
| Research and Development Expenses | 17.23 Million | 6.49 Million | 12.22 Million | - | 13.18 Million | 31.65 Million |
| Other Expenses | -35.63 Million | -422.02 Thousand | -38.89 Thousand | -1.85 Million | -471.82 Thousand | -1.2 Million |
| Cost and Expenses | 238.85 Million | 214.44 Million | 165.97 Million | 799.36 Million | 247.9 Million | 214.08 Million |
| Operating Income | 85.47 Million | 79.67 Million | 55.37 Million | 247.3 Million | 68.67 Million | 57 Million |
| Interest Expense | 5.49 Million | 5.4 Million | 4.58 Million | 14.33 Million | 4.67 Million | 7.29 Million |
| Income Tax Expense | 12.51 Million | 13.06 Million | 8.54 Million | 27.9 Million | 2 Million | 6.91 Million |
| Earnings before Tax | 85.31 Million | 75.99 Million | 55.34 Million | 245.45 Million | 68.2 Million | 57.38 Million |
| Net Income | 72.83 Million | 63.02 Million | 46.83 Million | 218.65 Million | 67.41 Million | 50.21 Million |
| Earnings Per Share Basic | 0.32 | 0.28 | 0.21 | - | 0.30 | 0.22 |
| Earnings Per Share Diluted | 0.32 | 0.28 | 0.21 | - | 0.30 | 0.22 |
| Weighted Average Shares Outstanding | 226.8 Million | 226.8 Million | 226.78 Million | 226.79 Million | 226.79 Million | 226.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 226.8 Million | 226.8 Million | 226.78 Million | 226.79 Million | 226.79 Million | 226.8 Million |
| Gross Margin | 0.42 | 0.39 | 0.43 | 0.41 | 0.38 | 0.44 |
| EBIT Margin | 0.27 | 0.37 | 0.27 | - | 0.22 | 0.23 |
| Profit Margin | 0.22 | 0.21 | 0.21 | 0.21 | 0.22 | 0.18 |
| EBITDA | 90.81 Million | 107.93 Million | 60.42 Million | - | 70.33 Million | 65.18 Million |
| Earnings Before Tax Margin | 0.26 | 0.27 | 0.24 | 0.24 | 0.22 | 0.20 |
BLRX
IMCR
3025
GRCAF
ANLT
GMN